Quick Answer
SkinHealth Systems Inc. reported R&D Expense of $5.63 million for fiscal year 2025.
SkinHealth Systems Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $5.63M | -10.6% |
| 2024 | $6.30M | -37.7% |
| 2023 | $10.10M | +19.6% |
| 2022 | $8.44M | +3.0% |
| 2021 | $8.20M | +140.4% |
| 2020 | $3.41M | -26.1% |
| 2019 | $4.61M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.70M | +53.2% | +35.7% |
| June 30, 2025 | $1.25M | +7.9% | +25.4% |
| March 31, 2025 | $998.0K | -64.4% | -9.9% |
| September 30, 2024 | $1.11M | -39.7% | -4.4% |
| June 30, 2024 | $1.16M | -59.8% | -58.7% |
| March 31, 2024 | $2.81M | +20.2% | +52.6% |
| September 30, 2023 | $1.84M | -15.1% | -36.2% |
| June 30, 2023 | $2.88M | +10.8% | +23.3% |
- SkinHealth Systems Inc. showed a decrease of -10.6% in R&D Expense compared to the prior fiscal year.
- Over the 2019–2025 period, SkinHealth Systems Inc.’s r&d expense has grown by 22.0% (from $4.61 million to $5.63 million).
- The most recent figure is from SkinHealth Systems Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: